FG unveils plans to expand pharmacists’ role in Nigeria’s healthcare delivery

Nigeria is moving to redefine the role of pharmacists from medicine dispensers to frontline healthcare providers, as the Federal Government seeks to close gaps in primary healthcare delivery and strengthen the country’s pharmaceutical supply chain.

The policy shift, announced under President Bola Tinubu’s Renewed Hope Agenda, was highlighted at the 2026 World Pharmacists Day ministerial press briefing, where the Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, represented by Mrs. Teshoma Dafeta, described pharmacists as critical to building a resilient and sustainable health system.

The emerging reforms could significantly change how Nigerians access basic healthcare, particularly in communities where pharmacies are often easier to reach than hospitals and primary healthcare centres.

Under the proposed direction, community pharmacists would increasingly participate in preventive and frontline care, including screening for hypertension and diabetes, health education, vaccination support and medication management.

The policy also places greater emphasis on clinical medication reviews, with pharmacists expected to identify potentially harmful drug interactions, monitor treatment and counsel patients on adherence.

The development comes amid persistent shortages of healthcare professionals and uneven access to medical services across Nigeria. Expanding pharmacists’ responsibilities could provide an additional channel for delivering basic health interventions, particularly at community level.

However, the expansion also raises questions about regulation, professional capacity and the ability of existing health institutions to coordinate an increasingly integrated model of care.

Beyond clinical services, the Federal Government is targeting vulnerabilities in the pharmaceutical supply chain.

The Ministry of Health is developing regulatory frameworks for e-pharmacy and other digital health platforms, with the objective of making online medicine distribution more transparent, traceable and safe.

The government is also seeking to increase domestic pharmaceutical production through updates to the National Drug Policy and incentives aimed at strengthening local manufacturing.

The strategy is intended to reduce dependence on imported medicines and improve Nigeria’s ability to maintain supplies during disruptions in global pharmaceutical markets.

READ ALSO; Why local production struggles to lower Nigeria’s medicine costs?

Professional development is another component of the reform agenda, with emphasis on continuing education, residency programmes and advanced clinical training for pharmacists.

At the same time, regulators are intensifying efforts against antimicrobial resistance, inappropriate medicine use and the circulation of substandard and falsified medical products.

The Pharmacy Council of Nigeria is responsible for professional standards, ethics and licensing of pharmacy premises, while the National Agency for Food and Drug Administration and Control is strengthening pharmacovigilance and market surveillance.

The National Health Insurance Authority is also expected to play a role in ensuring that expanded access to medicines remains consistent with affordability, safety and effectiveness.

Stakeholders including the Director of Food and Drug Services, Mrs. Olufowubi-Yusuf Adeola, as well as representatives of NAFDAC and the NHIA, stressed the importance of reliable access to safe medicines in achieving Universal Health Coverage.

The reforms therefore extend beyond changing the job description of pharmacists. They represent an attempt to use Nigeria’s existing pharmaceutical workforce to strengthen preventive healthcare, improve medicine safety, modernise distribution and reduce vulnerabilities in the national drug supply chain.

The effectiveness of the approach, however, will ultimately depend on how clearly responsibilities are defined, how professionals are trained and regulated, and whether enforcement mechanisms can keep pace with the expanding role of pharmacists and the growth of digital medicine platforms.